Transcriptomic signature predicts the distant relapse in patients with ER+ breast cancer treated with tamoxifen for five years.

Zhou, Hao; Lv, Qingfu; Guo, Zhaoji

Zhou, Hao; Lv, Qingfu; Guo, Zhaoji.

Affiliation

Zhou H; Department of General Surgery, The First Affiliated Hospital of SooChow University, Suzhou, Jiangsu 215006, P.R. China.
Lv Q; Department of General Surgery, The First Affiliated Hospital of SooChow University, Suzhou, Jiangsu 215006, P.R. China.
Guo Z; Department of General Surgery, The First Affiliated Hospital of SooChow University, Suzhou, Jiangsu 215006, P.R. China.

Mol Med Rep ; 17(2): 3152-3157, 2018 Feb.

Article in En | MEDLINE | ID: mdl-29257261

Subject(s)

Antineoplastic Agents, Hormonal/therapeutic use; Breast Neoplasms/drug therapy; Receptors, Estrogen/metabolism; Tamoxifen/therapeutic use; Amino Acyl-tRNA Synthetases/genetics; Amino Acyl-tRNA Synthetases/metabolism; Biomarkers, Tumor/genetics; Biomarkers, Tumor/metabolism; Breast Neoplasms/metabolism; Breast Neoplasms/mortality; Cyclin B2/genetics; Cyclin B2/metabolism; Databases, Factual; Female; Humans; Neoplasm Recurrence, Local; Nuclear Proteins/genetics; Nuclear Proteins/metabolism; Prognosis; Proportional Hazards Models; Risk Factors; Survival Rate; Transcriptome; mRNA Cleavage and Polyadenylation Factors/genetics; mRNA Cleavage and Polyadenylation Factors/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Receptors, Estrogen / Antineoplastic Agents, Hormonal Type of study: Etiology_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Mol Med Rep Year: 2018 Document type: Article Country of publication: Greece

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google